MSNCX
Price
$10.94
Change
+$0.01 (+0.09%)
Updated
Jun 30 closing price
Net Assets
577.57M
MSVAX
Price
$10.35
Change
+$0.01 (+0.10%)
Updated
Jun 30 closing price
Net Assets
347.8M
Interact to see
Advertisement

MSNCX vs MSVAX

MSNCX vs MSVAX Comparison Chart in %
View a ticker or compare two or three
VS
MSNCX vs. MSVAX commentary
Jul 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSNCX is a Hold and MSVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MSNCX has more cash in the bank: 578M vs. MSVAX (348M). MSNCX (3.29) and MSVAX (3.23) have matching dividends . MSNCX was incepted earlier than MSVAX: MSNCX (42 years) vs MSVAX (42 years). MSVAX (0.90) and MSNCX (0.86) have similar cost to investors . MSVAX is a more actively managed with annual turnover of: 9.00 vs. MSNCX (6.00). MSNCX (4%) and MSVAX (4%) have equivalent initial investment costs. MSNCX (1000) and MSVAX (1000) have matching initial minimum investment requirements. MSNCX (7.54) and MSVAX (7.20) have marching annual gain over last year. MSNCX return over 5 years is better than : 3.55 vs. MSVAX (2.54).
MSNCXMSVAXMSNCX / MSVAX
Total Expense Ratio0.840.82102%
Annual Report Gross Expense Ratio0.860.9096%
Fund Existence42 years42 years-
Gain YTD2.5952.129122%
Front Load4%4%100%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets578M348M166%
Annual Yield % from dividends3.293.23102%
Returns for 1 year7.547.20105%
Returns for 3 years12.0111.05109%
Returns for 5 years3.552.54140%
Returns for 10 years14.9314.32104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFIPX30.79N/A
N/A
Franklin Global Equity A
ETIHX58.38N/A
N/A
Eventide Healthcare & Life Sciences I
TICIX45.14N/A
N/A
Timothy Plan Israel Common Values I
RYIMX24.66N/A
N/A
Guggenheim Multi-Hedge Strategies I
PIIDX17.44N/A
N/A
Principal International Equity R-6